Search - tctmd.com

Displaying 541 - 560 of 567

Sort: Relevancy | Date

News Daily News

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

L.A. McKeown

April 15, 2011

News Conference News

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

Jason Kahn

April 04, 2011

News Industry News

Boston Scientific's Promus Element™ Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial

April 04, 2011

News Industry News

Boston Scientific ION™ Platinum Chromium Stent System Demonstrates Strong Performance in Analysis of PERSEUS and TAXUS ATLAS Clinical Trial Data

April 03, 2011

News Industry News

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

April 03, 2011

News Industry News

Boston Scientific Announces its ACC 2011 Schedule

March 29, 2011

News Industry News

Abbott to Present Data on Novel Vascular Technologies and XIENCE V® at ACC 2011

March 28, 2011

News Daily News

SYNTAX Analysis: PCI, CABG Offer Substantial Symptom Relief But Timing Differs

Caitlin E. Cox

March 16, 2011

News Daily News

IVUS Supports Effectiveness of Novel Stent with Bioabsorbable Polymer

L.A. McKeown

March 10, 2011

News Daily News

Studies Support DES Use in Diabetics, But Results Vary by Device

Caitlin E. Cox

March 08, 2011

News Industry News

Boston Scientific Announces European Approval and Launch of OMEGA™ Platinum Chromium Stent System

March 06, 2011

News Daily News

Autopsy Study: About One-Third of DES Contain New Atherosclerosis

March 01, 2011

News Daily News

Many Cardiovascular Devices Approved by FDA Without Sex-Specific Data

L.A. McKeown

February 28, 2011

News Daily News

New Dual-Drug DES Adds Cilostazol to Boost Effectiveness of Paclitaxel

Jason Kahn

February 23, 2011

News Daily News

Paclitaxel-Eluting Balloon Effective for DES Restenosis

February 22, 2011

News Industry News

Boston Scientific Launches PROMUS® Element™ and TAXUS® Element™ Stent Systems in India

February 16, 2011

News Conference News

SYNTAX Left Main: PCI Provides Similar Angina Relief to CABG at Lower Cost

Caitlin E. Cox

February 15, 2011

News Daily News

IVUS Study Investigates Mechanisms of DES Restenosis

Jason Kahn

February 06, 2011

News Daily News

Superiority of Xience V Over Taxus in Women Sustained at 3 Years

Leah Lawrence

February 03, 2011

News Industry News

Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Element™ Everolimus-Eluting Stent

January 25, 2011

Advertisement

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

Boston Scientific's Promus Element™ Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial

Boston Scientific ION™ Platinum Chromium Stent System Demonstrates Strong Performance in Analysis of PERSEUS and TAXUS ATLAS Clinical Trial Data

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

Boston Scientific Announces its ACC 2011 Schedule

Abbott to Present Data on Novel Vascular Technologies and XIENCE V® at ACC 2011

SYNTAX Analysis: PCI, CABG Offer Substantial Symptom Relief But Timing Differs

IVUS Supports Effectiveness of Novel Stent with Bioabsorbable Polymer

Studies Support DES Use in Diabetics, But Results Vary by Device

Boston Scientific Announces European Approval and Launch of OMEGA™ Platinum Chromium Stent System

Autopsy Study: About One-Third of DES Contain New Atherosclerosis

Many Cardiovascular Devices Approved by FDA Without Sex-Specific Data

New Dual-Drug DES Adds Cilostazol to Boost Effectiveness of Paclitaxel

Paclitaxel-Eluting Balloon Effective for DES Restenosis

Boston Scientific Launches PROMUS® Element™ and TAXUS® Element™ Stent Systems in India

SYNTAX Left Main: PCI Provides Similar Angina Relief to CABG at Lower Cost

IVUS Study Investigates Mechanisms of DES Restenosis

Superiority of Xience V Over Taxus in Women Sustained at 3 Years

Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Element™ Everolimus-Eluting Stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content